1 |
CUEVAS-DIAZ DURAN R, WEI H, KIM D H,et al. Long non-coding RNAs: important regulators in the development, function and disorders of the central nervous system[J]. Neuropathol Appl Neurobiol,2019,45(6):538-556.
|
2 |
BRIDGES M C, DAULAGALA A C, KOURTIDIS A. LNCcation: lncRNA localization and function[J]. J Cell Biol,2021,220(2):e202009045.
|
3 |
WANG B, SUEN C W, MA H, et al. The Roles of H19 in Regulating Inflammation and Aging[J]. Front Immunol,2020,11:579687.
|
4 |
白建杰,林春水,叶慧瑾,等. 丙泊酚下调H19抑制乳腺癌MDA-MB-231细胞的迁移和侵袭[J]. 南方医科大学学报,2016,36(9):1255-1259.
|
5 |
GE Y, LIN D, CUI B,et al. Effects of long noncoding RNA H19 on isoflurane-induced cognitive dysregulation by promoting neuroinflammation[J]. Neuroimmunomodulation,2022,29(2):117-127.
|
6 |
GABORY A, JAMMES H, DANDOLO L. The H19 locus: role of an imprinted non-coding RNA in growth and development[J]. Bioessays, 2010,32(6):473-480.
|
7 |
HASHEMI M, MOOSAVI M S, AVED H M,et al. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy[J]. Pharmacol Res,2022,184:106418.
|
8 |
汪乐新,刘超,马天龙,等. LncRNA H19调控肾小球足细胞焦亡中作用[J]. 实用医学杂志,2023,39(1):12-20.
|
9 |
BI Y, WANG Y, SUN X. Recent Advances of LncRNA H19 in Diabetes LncRNA H19 in Diabetes[J]. Horm Metab Res,2022,54(4):212-219.
|
10 |
HERNÁNDEZ-AGUILAR A I, LUCIANO-VILLA C A, TELLO-FLORES V A,et al. Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved: a systematic review[J]. Expert Rev Mol Diagn,2021,21(8):809-821.
|
11 |
ZHANG Y Y, BAO H L, DONG L X,et al. Silenced lncRNA H19 and up-regulated microRNA-129 accelerates viability and restrains apoptosis of PC12 cells induced by Aβ25-35 in a cellular model of Alzheimer's disease[J]. Cell Cycle,2021,20(1):112-125.
|
12 |
KRAUS T F J, HAIDER M, SPANNER J,et al. Altered Long Noncoding RNA Expression Precedes the Course of Parkinson's Disease-a Preliminary Report[J]. Mol Neurobiol,2017,54(4):2869-2877.
|
13 |
HAN S, REN M, KUANG T,et al. Cerebellar Long Noncoding RNA Expression Profile in a Niemann-Pick C Disease Mouse Model[J]. Mol Neurobiol,2021,58(11):5826-5836.
|
14 |
贾玉梅,朱才丰,杨坤,等. 艾灸督脉对APP/PS1双转基因小鼠mTOR/TFEB通路介导的自噬溶酶体功能及lncRNA H19表达的影响[J]. 针刺研究,2022,47(8):665-672.
|
15 |
ZHANG Y, XIA Q, LIN J. LncRNA H19 Attenuates Apoptosis in MPTP-Induced Parkinson's Disease Through Regulating miR-585-3p/PIK3R3[J]. Neurochem Res,2020,45(7):1700-1710.
|
16 |
JIANG J, PIAO X, HU S,et al. LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway[J]. Aging (Albany NY),2020,12(10):8820-8836.
|
17 |
NI W F, WU A M, LI Q L,et al. Induced human bone marrow stromal cells differentiate into neural cells by bFGF and cocultured with olfactory ensheathing cells[J]. Curr Stem Cell Res Ther,2014,9(4):291-296.
|
18 |
WU A M, NI W F, HUANG Z Y, et al. Analysis of differentially expressed lncRNAs in differentiation of bone marrow stem cells into neural cells[J]. J Neurol Sci,2015,351(1/2):160-167.
|
19 |
ZHU R, LIU X, HE Z. Long non-coding RNA H19 and MALAT1 gene variants in patients with ischemic stroke in a northern Chinese Han population[J]. Mol Brain,2018,11(1):58.
|
20 |
HUANG J, YANG J, LI J,et al. Association of long noncoding RNA H19 polymorphisms with the susceptibility and clinical features of ischemic stroke in southern Chinese Han population[J]. Metab Brain Dis,2019,34(4):1011-1021.
|
21 |
REZAEI M, MOKHTARI M J, BAYAT M,et al. Long non-coding RNA H19 expression and functional polymorphism rs217727 are linked to increased ischemic stroke risk[J]. BMC Neurol,2021,21(1):54.
|
22 |
LI H, TANG C, WANG D. LncRNA H19 promotes inflammatory response induced by cerebral ischemia-reperfusion injury through regulating the miR-138-5p-p65 axis[J]. Biochem Cell Biol,2020,98(4):525-536.
|
23 |
WANG J, CAO B, SUN R,et al. Exosome-transported Long Non-coding Ribonucleic Acid H19 Induces Blood-brain Barrier Disruption in Cerebral Ischemic Stroke Via the H19/micro Ribonucleic Acid-18a/Vascular Endothelial Growth factor Axis[J]. Neuroscience, 2022,500:41-51.
|
24 |
LI G, MA X, ZHAO H,et al. Long non-coding RNA H19 promotes leukocyte inflammation in ischemic stroke by targeting the miR-29b/C1QTNF6 axis[J]. CNS Neurosci Ther,2022,28(6):953-963.
|
25 |
WANG J, ZHAO H, FAN Z,et al. Long Noncoding RNA H19 Promotes Neuroinflammation in Ischemic Stroke by Driving Histone Deacetylase 1-Dependent M1 Microglial Polarization [J]. Stroke,2017,48(8):2211-2221.
|
26 |
FAN B, PAN W, WANG X,et al. Long noncoding RNA mediates stroke-induced neurogenesis[J]. Stem Cells,2020,38(8):973-985.
|
27 |
WANG J, CAO B, GAO Y,et al. Long Non-Coding RNA H19 positively associates with aspirin resistance in the patients of cerebral ischemic stroke[J]. Front Pharmacol,2020,11:580783.
|
28 |
LI Y, ZHANG Y, WALAYAT A,et al. The regulatory role of H19/miR-181a/ATG5 signaling in perinatal nicotine exposure-induced development of neonatal brain hypoxic-ischemic sensitive phenotype[J]. Int J Mol Sci,2022,23(13):6885.
|
29 |
ZHU H, WANG L, CHEN J,et al. Mechanisms underlying abnormal expression of lncRNA H19 in neonatal hypoxic-ischemic encephalopathy[J]. Am J Perinatol,2022,39(8):844-852.
|
30 |
KIM J M, MOON J, YU J S,et al. Altered long noncoding RNA profile after intracerebral hemorrhage[J]. Ann Clin Transl Neurol, 2019,6(10):2014-2025.
|
31 |
MAO S, HUANG H, CHEN X. LncRNA H19 aggravates brain injury in rats following experimental intracerebral hemorrhage via NF-κB Pathway[J]. Comput Math Methods Med,2022,2022:3017312.
|
32 |
CHEN B, WANG H, LV C,et al. Long non-coding RNA H19 protects against intracerebral hemorrhage injuries via regulating microRNA-106b-5p/acyl-CoA synthetase long chain family member 4 axis[J]. Bioengineered,2021,12(1):4004-4015.
|
33 |
袁敏,王素洁,李茜,等. LncRNA H19/Sirt3介导自噬在脑出血后损伤中的作用机制[J]. 实用医学杂志,2022,38(10):1213-1219.
|
34 |
YANG S, TANG W, HE Y,et al. Long non-coding RNA and microRNA-675/let-7a mediates the protective effect of melatonin against early brain injury after subarachnoid hemorrhage via targeting TP53 and neural growth factor[J]. Cell Death Dis,2018,9(2):99.
|
35 |
WU Z R, YAN L, LIU Y T,et al. Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumors[J]. Nat Commun,2018,9(1):4624.
|
36 |
ZHANG Y, LIU Y T, TANG H,et al. Exosome-Transmitted lncRNA H19 Inhibits the Growth of Pituitary Adenoma[J]. J Clin Endocrinol Metab,2019,104(12):6345-6356.
|
37 |
WU Z, ZHENG Y, XIE W,et al. The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonists[J]. Mol Cell Endocrinol,2020,518:111033.
|
38 |
ZHANG T, WANG Y R, ZENG F,et al. LncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumor growth through its derivative miR-675[J]. Eur Rev Med Pharmacol Sci,2016,20(23):4891-4897.
|
39 |
ZHENG Y, LU X, XU L,et al. MicroRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1[J]. Hum Pathol,2017,69:63-71.
|
40 |
WU W, HU Q, NIE E,et al. Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastoma[J]. Sci Rep,2017,7:45029.
|
41 |
GUANG N, WANG R, GUO W S,et al. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β- catenin signaling pathway[J]. Eur Rev Med Pharmacol Sci,2019,23(10):4243-4253.
|
42 |
ZHAO W, LIN X, HAN H,et al. Long noncoding RNA H19 contributes to the proliferation and autophagy of glioma cells through mTOR/ULK1 pathway[J]. Neuroreport,2021,32(5):352-358.
|
43 |
LIU P, HUANG X, WU H,et al. LncRNA-H19 gene plays a significant role in regulating glioma cell function[J]. Mol Genet Genomic Med,2021,9(10):e1480.
|
44 |
DUAN S, LI M, WANG Z,et al. H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-κB signaling[J]. Onco Targets Ther,2018,11:6395-6404.
|
45 |
SHEN L, XU M, WANG Z,et al. Prognostic evaluation of serum long non-coding RNA H19 for endoscopic keyhole surgery or craniotomy in glioma[J]. Ann Clin Biochem,2020,57(5):365-372.
|
46 |
HAN C L, GE M, LIU Y P,et al. Long non-coding RNA H19 contributes to apoptosis of hippocampal neurons by inhibiting let-7b in a rat model of temporal lobe epilepsy[J]. Cell Death Dis,2018,9(6):617.
|
47 |
HAN C L, LIU Y P, GUO C J,et al. The lncRNA H19 binding to let-7b promotes hippocampal glial cell activation and epileptic seizures by targeting Stat3 in a rat model of temporal lobe epilepsy[J]. Cell Prolif,2020,53(8): e12856.
|
48 |
JU H, YANG Z. H19 silencing decreases kainic acid-induced hippocampus neuron injury via activating the PI3K/AKT pathway via the H19/miR-206 axis[J]. Exp Brain Res,2022,240(7/8):2109-2120.
|
49 |
HAN C L, GE M, LIU Y P,et al. LncRNA H19 contributes to hippocampal glial cell activation via JAK/STAT signaling in a rat model of temporal lobe epilepsy[J]. J Neuroinflammation,2018,15(1):103.
|
50 |
XIE Y, WANG M, SHAO Y,et al. LncRNA H19 Regulates P-glycoprotein Expression Through the NF-κB Signaling Pathway in the Model of Status Epilepticus[J]. Neurochem Res,2023,48(3):929-941.
|
51 |
IWASAKI H, SAKAI A, MARUYAMA M,et al. Increased H19 long non-coding RNA expression in schwann cells in peripheral neuropathic pain[J]. J Nippon Med Sch,2019,86(4):215-221.
|
52 |
MENG L, ZHANG Y, HE X,et al. LncRNA H19 modulates neuropathic pain through miR-141/GLI2 axis in chronic constriction injury (CCI) rats[J]. Transpl Immunol,2022,71:101526.
|
53 |
谢玉海,朵海珍,王学军. 利多卡因通过LncRNA H19/miR-671-5p分子轴调控胃癌细胞增殖,迁移及侵袭[J]. 中国免疫学杂志,2022,38(12):1475-1479.
|
54 |
ZHANG X, FU Q, XU L,et al. Dexmedetomidine postconditioning alleviates hypoxia/reoxygenation injury in senescent myocardial cells by regulating lncRNA H19 and m6A modification[J]. Oxid Med Cell Longev, 2020,2020:7059751.
|